Equities

Shanghai Sanyou Medical Co Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Shanghai Sanyou Medical Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (CNY)21.07
  • Today's Change-0.16 / -0.75%
  • Shares traded1.58m
  • 1 Year change+34.13%
  • Beta1.0606
Data delayed at least 15 minutes, as of Feb 11 2026.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Shanghai Sanyou Medical Co Ltd is a China-based company primarily engaged in the research and development, manufacture and sales of medical orthopedics implants and ultrasonic power equipment and consumables. The Company’s main products include spinal implant consumables, trauma implant consumables, ultrasonic bone dynamic systems, vertebroplasty consumables and other products. The Company is also engaged in the research and development and production of supporting surgical tools. The Company mainly conducts business in the domestic and overseas markets.

  • Revenue in CNY (TTM)512.33m
  • Net income in CNY64.88m
  • Incorporated2005
  • Employees514.00
  • Location
    Shanghai Sanyou Medical Co LtdNo.1988 Jiatang Road, Jiading DistrictSHANGHAI 201815ChinaCHN
  • Phone+86 2 158266088
  • Fax+86 2 159990826
  • Websitehttps://www.sanyoumed.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Qingdao NovelBeam Technology Co Ltd571.80m174.33m5.85bn841.0033.624.44--10.231.451.454.7610.990.38170.99325.67679,901.1011.3912.7012.6114.1164.3463.1529.8433.963.4351.040.105840.95-5.9011.86-7.1113.4813.44--
Jiangsu Bioperfectus Technologies Co Ltd339.03m-25.96m5.88bn592.00--1.98--17.36-0.3096-0.30964.0435.380.09031.856.13572,683.70-0.691920.36-0.79624.5558.2262.71-7.6631.893.22--0.132928.76-13.293.9099.46---9.88--
Shenzhen Lifotronic Technology Co Ltd1.05bn251.02m5.93bn1.67k23.412.82--5.620.59070.59072.474.900.38552.515.74631,202.608.9814.0312.1017.3461.0362.4623.3027.253.00--0.140639.010.202422.125.1227.99-1.6318.64
Cowealth Medical China Co Ltd777.03m-11.37m6.74bn203.00--6.10--8.67-0.0285-0.02851.972.780.52063.321.003,827,724.00-0.71684.75-0.93936.3516.3820.19-1.385.562.65--0.022933.36-14.05-2.15-41.58-16.312.73--
Shanghai Sanyou Medical Co Ltd512.33m64.88m7.08bn514.0094.333.41--13.820.22510.22511.586.220.22130.52636.23996,747.102.516.732.867.7873.3583.3111.3325.253.81--0.020418.72-1.485.06-88.00-34.86-14.02--
Beijing Chunlizhengda Mdicl Instr Co Ltd1.05bn255.37m7.80bn1.24k34.122.95--7.400.67290.67292.787.780.29950.64373.48851,792.407.269.448.5511.5264.9972.1524.2325.015.09--0.0000724.89-33.32-1.18-55.01-11.99-17.97--
Shenzhen YHLO Biotech Co Ltd1.90bn143.32m7.81bn1.75k52.942.88--4.100.2580.2583.434.740.45751.104.011,086,410.003.2313.954.0619.5762.9555.777.0519.421.403.240.271433.21-2.0218.05-15.0622.9035.88--
Data as of Feb 11 2026. Currency figures normalised to Shanghai Sanyou Medical Co Ltd's reporting currency: Chinese Yuan Renminbi CNY

Institutional shareholders

13.64%Per cent of shares held by top holders
HolderShares% Held
Rongtong Fund Management Co., Ltd.as of 30 Jun 202518.37m5.85%
China Southern Asset Management Co., Ltd.as of 30 Jun 20259.11m2.90%
Baoying Fund Management Co., Ltd.as of 30 Jun 20253.24m1.03%
Da Cheng Fund Management Co., Ltd.as of 15 Sep 20253.11m0.99%
Huatai Asset Management Co., Ltd.as of 15 Sep 20252.19m0.70%
Nuode Asset Management Co., Ltd.as of 15 Sep 20252.01m0.64%
ICBC UBS Asset Management Co. Ltd.as of 30 Jun 20251.52m0.49%
Caitong Fund Management Co., Ltd.as of 15 Sep 20251.32m0.42%
Essence Fund Co., Ltd.as of 30 Jun 2025990.13k0.32%
China Merchants Fund Management Co., Ltd.as of 30 Jun 2025934.33k0.30%
More ▼
Data from 30 Jun 2025 - 05 Feb 2026Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.